X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1583) 1583
Publication (177) 177
Book Review (152) 152
Book Chapter (9) 9
Conference Proceeding (4) 4
Dissertation (4) 4
Magazine Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1277) 1277
oxidative stress (1043) 1043
humans (933) 933
isoprostanes (884) 884
male (773) 773
female (638) 638
animals (455) 455
adult (384) 384
middle aged (383) 383
lipid-peroxidation (372) 372
lipid peroxidation (317) 317
in-vivo (303) 303
biochemistry & molecular biology (284) 284
dinoprost - analogs & derivatives (275) 275
isoprostane (273) 273
aged (255) 255
antioxidants (240) 240
f-2-isoprostanes (237) 237
oxidative stress - drug effects (226) 226
biomarkers - blood (224) 224
inflammation (224) 224
rats (194) 194
isoprostanes - blood (183) 183
plasma (182) 182
endocrinology & metabolism (180) 180
oxidative stress - physiology (178) 178
biomarkers (174) 174
isoprostanes - metabolism (145) 145
free radicals (140) 140
oxidant stress (133) 133
isoprostanes - urine (129) 129
atherosclerosis (128) 128
article (127) 127
lipids (127) 127
analysis (125) 125
risk factors (125) 125
f2-isoprostanes - blood (124) 124
mice (124) 124
low-density-lipoprotein (122) 122
peripheral vascular disease (122) 122
dinoprost - blood (120) 120
f2-isoprostanes (114) 114
pharmacology & pharmacy (113) 113
research (113) 113
antioxidants - metabolism (111) 111
nutrition & dietetics (111) 111
hypertension (103) 103
physiology (103) 103
abridged index medicus (101) 101
disease (101) 101
physiological aspects (101) 101
biomarkers - urine (99) 99
medicine (99) 99
cell biology (96) 96
vitamin-e (95) 95
cardiac & cardiovascular systems (93) 93
health aspects (91) 91
mass spectrometry (91) 91
adolescent (90) 90
antioxidants - pharmacology (88) 88
cardiovascular-disease (88) 88
case-control studies (88) 88
oxidation-reduction (88) 88
stress (85) 85
lipid peroxidation - drug effects (84) 84
rats, sprague-dawley (82) 82
biomarkers - metabolism (81) 81
diet (81) 81
dietary supplements (80) 80
antioxidant (79) 79
prostaglandins (78) 78
dinoprost - urine (77) 77
nitric oxide (77) 77
time factors (77) 77
nitric-oxide (76) 76
oxidation (76) 76
young adult (76) 76
pregnancy (75) 75
c-reactive protein (73) 73
diabetes (72) 72
neurosciences (72) 72
markers (69) 69
rodents (69) 69
vitamin e (68) 68
blood pressure (67) 67
chemical compounds (67) 67
glutathione (67) 67
metabolites (65) 65
supplementation (65) 65
dinoprost - metabolism (64) 64
urine (64) 64
exercise (63) 63
prostaglandin (63) 63
child (62) 62
f2-isoprostanes - urine (62) 62
medicine, research & experimental (62) 62
superoxide (62) 62
disease models, animal (61) 61
risk (61) 61
aged, 80 and over (60) 60
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1586) 1586
Polish (4) 4
Japanese (2) 2
Chinese (1) 1
Czech (1) 1
French (1) 1
German (1) 1
Italian (1) 1
Portuguese (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 10/2015, Volume 10, Issue 10, pp. e0138904 - e0138904
Object Studies have suggested that depression was accompanied by oxidative stress dysregulation, including abnormal total antioxidant capacity (TAC),... 
SERUM-LIPID CONCENTRATIONS | TERM ANTIDEPRESSANT TREATMENT | AUTOIMMUNE RESPONSES | NITROSATIVE STRESS | PLASMA-LEVELS | MOOD DISORDERS | MULTIDISCIPLINARY SCIENCES | NITRIC-OXIDE | MAJOR DEPRESSION | IMMUNE-INFLAMMATORY MARKERS | TOTAL ANTIOXIDANT CAPACITY | Aryldialkylphosphatase - blood | Cross-Sectional Studies | F2-Isoprostanes - blood | Albumins - metabolism | Lipoproteins, HDL - blood | Antioxidants - metabolism | Humans | Oxidative Stress - physiology | Depressive Disorder - drug therapy | Biomarkers - blood | Depressive Disorder - metabolism | Case-Control Studies | Antidepressive Agents - therapeutic use | Depression - drug therapy | Depression - metabolism | Malondialdehyde - blood | Lipid Peroxidation - drug effects | Ascorbic Acid - blood | Uric Acid - blood | Oxidative Stress - drug effects | Depressive Disorder - blood | Depression - blood | Oxidative stress | Complications and side effects | Genetic aspects | Research | Depression, Mental | Risk factors | Drugs | Brain | Ascorbic acid | Control methods | Mental depression | Proteins | Antioxidants | Red blood cells | Peroxide | Vitamin C | Oxidation | Supplementation | Damage | Deoxyribonucleic acid--DNA | Stresses | Immunoglobulins | Sensitivity analysis | Free radicals | Markers | Albumin | Data processing | Uric acid | Paraoxonase | Assessments | Patients | Chemical compounds | Malondialdehyde | Zinc | Cholesterol | Studies | Isoprostanes | Lipoproteins | Hospitals | Acids | Vasoactive intestinal peptide | Clinical medicine | Nitrogen dioxide | Psychiatry | Index Medicus | Deoxyribonucleic acid | DNA
Journal Article
Cancer Letters, ISSN 0304-3835, 2008, Volume 272, Issue 1, pp. 141 - 147
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 2015, Volume 113, Issue 2, pp. 289 - 296
Summary Platelets from patients with type 2 diabetes are characterised by hyperactivation and high level of oxidative stress. Docosahexaenoic acid (DHA) may... 
Cellular Haemostasis and Platelets | Isoprostane | Platelet aggregation | Arachidonic acid | Vitamin E | Plasma and platelet lipid composition | arachidonic acid | LIPID-PEROXIDATION | vitamin E | IMPAIRED GLUCOSE-TOLERANCE | RISK | PURIFIED EICOSAPENTAENOIC ACID | CHROMATOGRAPHY | plasma and platelet lipid composition | BLOOD-PLATELETS | PLASMA | POLYUNSATURATED FATTY-ACIDS | PERIPHERAL VASCULAR DISEASE | isoprostane | PROSTAGLANDIN | HEMATOLOGY | AGGREGATION | Dinoprost - blood | Arachidonic Acid - metabolism | Humans | Middle Aged | alpha-Tocopherol - blood | Dose-Response Relationship, Drug | Lipids - blood | Lipid Peroxidation - drug effects | Postmenopause | Female | Phospholipids - blood | Collagen - pharmacology | Dinoprost - analogs & derivatives | Platelet Aggregation - drug effects | Fatty Acids - blood | Blood Platelets - drug effects | Docosahexaenoic Acids - therapeutic use | Membrane Lipids - blood | F2-Isoprostanes - urine | Double-Blind Method | Administration, Oral | Blood Platelets - chemistry | Antioxidants - pharmacology | Diabetes Mellitus, Type 2 - urine | Thromboxane B2 - analogs & derivatives | Cross-Over Studies | Docosahexaenoic Acids - pharmacology | Antioxidants - therapeutic use | Diabetes Mellitus, Type 2 - blood | Thromboxane B2 - urine | Thromboxane B2 - blood | Oxidative Stress - drug effects | Diabetes Mellitus, Type 2 - drug therapy | Dietary Supplements
Journal Article
Journal Article
Atherosclerosis, ISSN 0021-9150, 2013, Volume 228, Issue 1, pp. 217 - 223
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 08/2007, Volume 92, Issue 8, pp. 3068 - 3075
Journal Article
Journal Article
Cardiovascular Diabetology, ISSN 1475-2840, 10/2017, Volume 16, Issue 1, pp. 138 - 138
Background: Sodium-glucose cotransporter-2 inhibitors reduce blood pressure (BP) and renal and cardiovascular events in patients with type 2 diabetes through... 
Type 2 diabetes | Flow-mediated dilation | Dapagliflozin | Thiazide diuretics | Pulse wave velocity | SGLT2-inhibitors | Resistive index | Endothelium | METABOLIC SYNDROME | CARDIAC & CARDIOVASCULAR SYSTEMS | PULSE-WAVE VELOCITY | MELLITUS | BLOOD-PRESSURE | HYPERTENSIVE PATIENTS | BRACHIAL-ARTERY | ENDOCRINOLOGY & METABOLISM | NITRIC-OXIDE | SGLT2 INHIBITION | EMPAGLIFLOZIN | Blood Glucose - physiology | Kidney - blood supply | Humans | Middle Aged | Endothelium, Vascular - drug effects | Male | Vascular Resistance - physiology | Vascular Resistance - drug effects | Adult | Female | Glucosides - therapeutic use | Blood Pressure - drug effects | Blood Pressure - physiology | Benzhydryl Compounds - therapeutic use | Kidney - physiopathology | Glucosides - pharmacology | Kidney - drug effects | Endothelium, Vascular - physiopathology | Sodium-Glucose Transporter 2 - antagonists & inhibitors | Blood Glucose - drug effects | Diabetes Mellitus, Type 2 - blood | Pilot Projects | Diabetes Mellitus, Type 2 - physiopathology | Vascular Stiffness - drug effects | Vascular Stiffness - physiology | Aged | Benzhydryl Compounds - pharmacology | Diabetes Mellitus, Type 2 - drug therapy | Cohort Studies | Diuresis | Oxidative stress | Renal function | Glucose | Metabolic syndrome | Vasodilation | Ultrasonic imaging | Mathematical analysis | Rodents | Atherosclerosis | Aorta | Stiffness | Blood pressure | Magnesium | Diabetes mellitus (non-insulin dependent) | Hypertension | Kidneys | Diabetes mellitus | Mortality | Hydrochlorothiazide | Patients | Chemical compounds | Variance analysis | Velocity | Studies | Isoprostanes | Sodium | Dilation | Flow velocity | Gastrointestinal surgery | Diabetes | Wave velocity | Veins & arteries | Index Medicus
Journal Article
Journal Article
Journal of Nutrition, ISSN 0022-3166, 02/2014, Volume 144, Issue 2, pp. 193 - 201
Journal Article
American Journal of Clinical Nutrition, ISSN 0002-9165, 02/2006, Volume 83, Issue 2, pp. 237 - 243
Background: Evidence suggests that ruminant trans fatty acids (FAs), such as vaccenic acid, do not increase the risk of ischemic heart disease (IHD). However,... 
Isoprostanes | Lipoproteins | Ruminant trans fatty acid | C-reactive protein | Vaccenic acid | Men | Milk fat | Insulin | HDL cholesterol | insulin | CONJUGATED LINOLEIC-ACID | HUMANS | RISK | SERUM | DIETARY-INTAKE | isoprostanes | SUPPLEMENTATION | WOMEN | NUTRITION & DIETETICS | vaccenic acid | men | ruminant trans fatty acid | milk fat | HDL-CHOLESTEROL | CORONARY-HEART-DISEASE | lipoproteins | Butter - analysis | Cholesterol - blood | Fatty Acids, Monounsaturated - administration & dosage | Humans | Male | Isomerism | Cholesterol - chemistry | Oleic Acids - metabolism | Lipids - chemistry | C-Reactive Protein - metabolism | Cattle | Fatty Acids, Monounsaturated - metabolism | Lipids - blood | Adult | Trans Fatty Acids - administration & dosage | Cholesterol, HDL - chemistry | Myocardial Ischemia - epidemiology | Double-Blind Method | Trans Fatty Acids - metabolism | Risk Factors | Myocardial Ischemia - blood | Lipoproteins - chemistry | Lipoproteins - blood | Insulin - metabolism | Animals | Blood Coagulation - drug effects | Oleic Acids - administration & dosage | Cholesterol, HDL - blood | Lipoproteins - drug effects | Oxidative Stress - drug effects | Health aspects | Monounsaturated fatty acids | Proteins | Butter | Lipids | Oxidation | Fatty acids | Index Medicus | Abridged Index Medicus | Lipids/blood/chemistry | Lipoproteins; HDL Cholesterol/blood/chemistry | Lipoproteins/blood/chemistry/drug effects | Blood Coagulation/drug effects | Butter/analysis | Oxidative Stress/drug effects | Trans Fatty Acids/administration & dosage/metabolism | Myocardial Ischemia/blood/epidemiology | Oleic Acids/administration & dosage/metabolism | Fatty Acids; Monounsaturated/administration & dosage/metabolism | Insulin/metabolism | Cholesterol/blood/chemistry | C-Reactive Protein/metabolism | Research Support; Non-U.S. Gov't
Journal Article